Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 10 years
- Director since
- 2023
10 years of board service in total across 3 boards, counting each seat separately. Longest: Corcept Therapeutics Incorporated, 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Corcept Therapeutics Incorporated May 21, 202687.5%
-
Corcept Therapeutics Incorporated June 10, 202598.9%
-
Cerus Corporation June 5, 202490.3%
-
Corcept Therapeutics Incorporated May 17, 202499.6%
-
Corcept Therapeutics Incorporated May 19, 202395.0%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 10, 2026 | Corcept Therapeutics Incorporated | Option exercise | +1,100 | $14.08 | $15,488 |
| Nov 10, 2026 | Corcept Therapeutics Incorporated | Option exercise | +400 | $10.50 | $4,200 |
| Nov 10, 2026 | Corcept Therapeutics Incorporated | Open-market sale | −1,500 | $74.07 | $111,105 |
| Oct 10, 2025 | Corcept Therapeutics Incorporated | Option exercise | +2,200 | $14.08 | $30,976 |
| Oct 10, 2025 | Corcept Therapeutics Incorporated | Open-market sale | −2,200 | $87.54 | $192,588 |
| Sep 10, 2025 | Corcept Therapeutics Incorporated | Option exercise | +2,200 | $14.08 | $30,976 |
| Sep 10, 2025 | Corcept Therapeutics Incorporated | Open-market sale | −2,200 | $72.45 | $159,390 |
| Aug 11, 2025 | Corcept Therapeutics Incorporated | Option exercise | +2,200 | $14.08 | $30,976 |
| Aug 11, 2025 | Corcept Therapeutics Incorporated | Open-market sale | −2,200 | $72.30 | $159,060 |
| Jul 10, 2025 | Corcept Therapeutics Incorporated | Option exercise | +2,200 | $14.08 | $30,976 |
| Jul 10, 2025 | Corcept Therapeutics Incorporated | Open-market sale | −2,200 | $71.08 | $156,376 |
| Jun 10, 2025 | Corcept Therapeutics Incorporated | Option exercise | +2,200 | $14.08 | $30,976 |
| Jun 10, 2025 | Corcept Therapeutics Incorporated | Open-market sale | −2,200 | $70.61 | $155,342 |
| Jun 3, 2025 | Cerus Corporation | Grant or award | +60,000 | — | — |
| May 12, 2025 | Corcept Therapeutics Incorporated | Option exercise | +1,800 | $12.13 | $21,834 |
Questions about Daniel N. Swisher Jr.
What boards is Daniel N. Swisher Jr. on?
Daniel N. Swisher Jr. sits on the boards of Cerus Corporation, Corcept Therapeutics Incorporated and Protagonist Therapeutics Inc.
How long has Daniel N. Swisher Jr. served on boards?
Our records show at least 10 years of board service across 3 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.